Overexpression of cytotoxic T-lymphocyte-associated antigen-4 prevents atherosclerosis in mice

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 36, Issue 6, 2016, Pages 1141-1151

  Matsumoto, Takuya ^a   Sasaki, Naoto ^a   Yamashita, Tomoya ^a   Emoto, Takuo ^a   Kasahara, Kazuyuki ^a   Mizoguchi, Taiji ^a   Hayashi, Tomohiro ^a   Yodoi, Keiko ^a   Kitano, Naoki ^a   Saito, Takashi ^b,c   Yamaguchi, Tomoyuki ^c   Hirata, Ken Ichi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Institute of Physical and Chemical Research   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

atherosclerosis; dendritic cells; immune system; inflammation; T lymphocytes

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLYCOPROTEIN P 15095; APOLIPOPROTEIN E; CD86 PROTEIN, MOUSE; CTLA4 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ROOT; ARTICLE; ATHEROSCLEROSIS; CD4+ T LYMPHOCYTE; CELL MATURATION; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; HYPERLIPOPROTEINEMIA TYPE 3; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; AORTA; AORTIC DISEASES; ATHEROSCLEROTIC PLAQUE; C57BL MOUSE; CELL CULTURE; DEFICIENCY; FEMALE; GENETICS; GENOTYPE; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; MALE; METABOLISM; PATHOLOGY; PHENOTYPE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TRANSGENIC MOUSE; UPREGULATION;

ANIMALS; ANTIGENS, CD11C; ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, CD86; AORTA; AORTIC DISEASES; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CELL PROLIFERATION; CELLS, CULTURED; CTLA-4 ANTIGEN; DENDRITIC CELLS; FEMALE; GENOTYPE; LYMPHOCYTE ACTIVATION; MACROPHAGES; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; PHENOTYPE; PLAQUE, ATHEROSCLEROTIC; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; UP-REGULATION;

EID: 84964042170     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.115.306848     Document Type: Article

References (31)

1. Hansson GK, Hermansson A, The immune system in atherosclerosis. Nat Immunol 2011 12 204 212. doi: 10.1038/ni.2001
2. Ait-Oufella H, Sage AP, Mallat Z, Tedgui A, Adaptive (T and B cells) immunity and control by dendritic cells in atherosclerosis. Circ Res 2014 114 1640 1660. doi: 10.1161/CIRCRESAHA.114.302761
3. Ait-Oufella H, Salomon BL, Potteaux S, Robertson AK, Gourdy P, Zoll J, Merval R, Esposito B, Cohen JL, Fisson S, Flavell RA, Hansson GK, Klatzmann D, Tedgui A, Mallat Z, Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med 2006 12 178 180. doi: 10.1038/nm1343
4. Klingenberg R, Gerdes N, Badeau RM, Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis. J Clin Invest 2013 123 1323 1334. doi: 10.1172/JCI63891
5. Sasaki N, Yamashita T, Kasahara K, Takeda M, Hirata K, Regulatory T cells and tolerogenic dendritic cells as critical immune modulators in atherogenesis. Curr Pharm Des 2015 21 1107 1117
6. Gotsman I, Sharpe AH, Lichtman AH, T-cell costimulation and coinhibition in atherosclerosis. Circ Res 2008 103 1220 1231. doi: 10.1161/CIRCRESAHA.108.182428
7. Greenwald RJ, Freeman GJ, Sharpe AH, The B7 family revisited. Annu Rev Immunol 2005 23 515 548. doi: 10.1146/annurev.immunol.23.021704.115611
8. Buono C, Pang H, Uchida Y, Libby P, Sharpe AH, Lichtman AH, B7-1/B7-2 costimulation regulates plaque antigen-specific T-cell responses and atherogenesis in low-density lipoprotein receptor-deficient mice. Circulation 2004 109 2009 2015. doi: 10.1161/01.CIR.0000127121.16815.F1
9. Wing K, Yamaguchi T, Sakaguchi S, Cell-autonomous and -non-autonomous roles of CTLA-4 in immune regulation. Trends Immunol 2011 32 428 433. doi: 10.1016/j.it.2011.06.002
10. Waterhouse P, Penninger JM, Timms E, Wakeham A, Shahinian A, Lee KP, Thompson CB, Griesser H, Mak TW, Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 1995 270 985 988
11. Wellcome Trust Case Control Consortium Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007 447 661 678
12. Kuehn HS, Ouyang W, Lo B, Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4. Science 2014 345 1623 1627. doi: 10.1126/science.1255904
13. Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T, Miyara M, Fehervari Z, Nomura T, Sakaguchi S, CTLA-4 control over Foxp3+ regulatory T cell function. Science 2008 322 271 275. doi: 10.1126/science.1160062
14. Bour-Jordan H, Esensten JH, Martinez-Llordella M, Penaranda C, Stumpf M, Bluestone JA, Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/ B7 family. Immunol Rev 2011 241 180 205. doi: 10.1111/j.1600-065X.2011.01011.x
15. Ma K, Lv S, Liu B, Liu Z, Luo Y, Kong W, Xu Q, Feng J, Wang X, CTLA4-IgG ameliorates homocysteine-accelerated atherosclerosis by inhibiting T-cell overactivation in apoE(-/-) mice. Cardiovasc Res 2013 97 349 359. doi: 10.1093/cvr/cvs330
16. Ewing MM, Karper JC, Abdul S, de Jong RC, Peters HA, de Vries MR, Redeker A, Kuiper J, Toes RE, Arens R, Jukema JW, Quax PH, T-cell co-stimulation by CD28-CD80/86 and its negative regulator CTLA-4 strongly influence accelerated atherosclerosis development. Int J Cardiol 2013 168 1965 1974. doi: 10.1016/j.ijcard.2012.12.085
17. Takahashi S, Kataoka H, Hara S, Yokosuka T, Takase K, Yamasaki S, Kobayashi W, Saito Y, Saito T, In vivo overexpression of CTLA-4 suppresses lymphoproliferative diseases and thymic negative selection. Eur J Immunol 2005 35 399 407. doi: 10.1002/eji.200324746
18. Engelhardt JJ, Sullivan TJ, Allison JP, CTLA-4 overexpression inhibits T cell responses through a CD28-B7-dependent mechanism. J Immunol 2006 177 1052 1061
19. Gotsman I, Grabie N, Dacosta R, Sukhova G, Sharpe A, Lichtman AH, Proatherogenic immune responses are regulated by the PD-1/PD-L pathway in mice. J Clin Invest 2007 117 2974 2982. doi: 10.1172/JCI31344
20. Sakaguchi S, Yamaguchi T, Nomura T, Ono M, Regulatory T cells and immune tolerance. Cell 2008 133 775 787. doi: 10.1016/j.cell.2008.05.009
21. Mallat Z, Gojova A, Brun V, Esposito B, Fournier N, Cottrez F, Tedgui A, Groux H, Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice. Circulation 2003 108 1232 1237. doi: 10.1161/01.CIR.0000089083.61317.A1
22. Sasaki N, Yamashita T, Takeda M, Shinohara M, Nakajima K, Tawa H, Usui T, Hirata K, Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice. Circulation 2009 120 1996 2005. doi: 10.1161/CIRCULATIONAHA.109.863431
23. Wigren M, Björkbacka H, Andersson L, Ljungcrantz I, Fredrikson GN, Persson M, Bryngelsson C, Hedblad B, Nilsson J, Low levels of circulating CD4+FoxP3+ T cells are associated with an increased risk for development of myocardial infarction but not for stroke. Arterioscler Thromb Vasc Biol 2012 32 2000 2004. doi: 10.1161/ATVBAHA.112.251579
24. Emoto T, Sasaki N, Yamashita T, Kasahara K, Yodoi K, Sasaki Y, Matsumoto T, Mizoguchi T, Hirata K, Regulatory/effector T-cell ratio is reduced in coronary artery disease. Circ J 2014 78 2935 2941
25. Kasahara K, Sasaki N, Yamashita T, Kita T, Yodoi K, Sasaki Y, Takeda M, Hirata K, CD3 antibody and IL-2 complex combination therapy inhibits atherosclerosis by augmenting a regulatory immune response. J Am Heart Assoc 2014 3 e000719. doi: 10.1161/JAHA.113.000719
26. Kita T, Yamashita T, Sasaki N, Kasahara K, Sasaki Y, Yodoi K, Takeda M, Nakajima K, Hirata K, Regression of atherosclerosis with anti-CD3 antibody via augmenting a regulatory T-cell response in mice. Cardiovasc Res 2014 102 107 117. doi: 10.1093/cvr/cvu002
27. Bachmann MF, Köhler G, Ecabert B, Mak TW, Kopf M, Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous. J Immunol 1999 163 1128 1131
28. Qureshi OS, Zheng Y, Nakamura K, Attridge K, Manzotti C, Schmidt EM, Baker J, Jeffery LE, Kaur S, Briggs Z, Hou TZ, Futter CE, Anderson G, Walker LS, Sansom DM, Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science 2011 332 600 603. doi: 10.1126/science.1202947
29. Collins AV, Brodie DW, Gilbert RJ, Iaboni A, Manso-Sancho R, Walse B, Stuart DI, van der Merwe PA, Davis SJ, The interaction properties of costimulatory molecules revisited. Immunity 2002 17 201 210
30. Grohmann U, Orabona C, Fallarino F, Vacca C, Calcinaro F, Falorni A, Candeloro P, Belladonna ML, Bianchi R, Fioretti MC, Puccetti P, CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat Immunol 2002 3 1097 1101. doi: 10.1038/ni846
31. Hodi FS, Oday SJ, McDermott DF, Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010 363 711 723. doi: 10.1056/NEJMoa1003466